Two of the World’s Leading Providers of Technologies and Services to the Minimally Invasive Medical Device Industry Combine; Company to be Known as Creganna – Tactx Medical; Extended Global Reach, Enhanced Technology Depth and a Presence in Key Medical Device Clusters Worldwide

GALWAY, IRELAND & CAMPBELL, CA, January 4th, 2010 -- Creganna, a leading supplier of technologies and services to medical device and lifesciences companies today announced that it has acquired Avalon Medical Services Pte Ltd. which trades as Tactx Medical Inc.

 The company will be known as Creganna – Tactx Medical and will be positioned as a world leader in the provision of technologies and services for minimally invasive delivery and access devices.

 Commenting on today’s announcement, Helen Ryan, CEO Creganna, said:

"This move represents a key step in Creganna’s vision to build a leading global medical technology company. Tactx Medical, with its strong market reputation, is a true fit for Creganna.

 Our customers, medical device companies, are increasingly looking to strategic partners to fulfill more of their supply chain requirements. With our global locations, combined technologies and range of services Creganna – Tactx Medical is strategically positioned to meet these evolving needs.

 This move firmly positions Creganna – Tactx Medical within the top ten global providers of technologies and services to minimally invasive medical device companies."

 A Partnership that Makes Sense

Creganna – Tactx Medical, with locations in California, Minnesota, Massachusetts, Singapore and Ireland will have a presence in many of the key medical device clusters globally enabling stronger partnerships with customers.

Combined, the two companies will offer a complete range of technologies and services for minimally invasive delivery and access devices, with a specialist competency in the design and manufacturing of high end therapeutic catheters.

The market for minimally invasive medical devices continues to grow. In parallel, the market for outsourced products and services is also evolving and forecast to grow.

Creganna – Tactx Medical is positioned to benefit from these trends.

Creganna – Tactx Medical’s customers provide minimally invasive medical devices for clinical applications including interventional cardiology, neurology, peripheral vascular, cardiac rhythm management and endoscopy.

Creganna – Tactx Medical will have more than 800 staff worldwide and a combined revenue of $110 million in 2009.

Barclays Bank Ireland, HSBC Corporate Banking Ireland and Bank of Ireland advised on the deal. Terms of the transaction were not disclosed.